377 related articles for article (PubMed ID: 25991488)
1. The diagnostic efficacy of quantitative liver MR imaging with diffusion-weighted, SWI, and hepato-specific contrast-enhanced sequences in staging liver fibrosis--a multiparametric approach.
Feier D; Balassy C; Bastati N; Fragner R; Wrba F; Ba-Ssalamah A
Eur Radiol; 2016 Feb; 26(2):539-46. PubMed ID: 25991488
[TBL] [Abstract][Full Text] [Related]
2. Prediction of high-stage liver fibrosis using ADC value on diffusion-weighted imaging and quantitative enhancement ratio at the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI at 1.5 T.
Harada TL; Saito K; Araki Y; Matsubayashi J; Nagao T; Sugimoto K; Tokuuye K
Acta Radiol; 2018 May; 59(5):509-516. PubMed ID: 28853292
[TBL] [Abstract][Full Text] [Related]
3. Prospective comparison of diffusion-weighted MRI and dynamic Gd-EOB-DTPA-enhanced MRI for detection and staging of hepatic fibrosis in primary sclerosing cholangitis.
Keller S; Sedlacik J; Schuler T; Buchert R; Avanesov M; Zenouzi R; Lohse AW; Kooijman H; Fiehler J; Schramm C; Yamamura J
Eur Radiol; 2019 Feb; 29(2):818-828. PubMed ID: 30014204
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effect of region-of-interest methods using gadoxetic acid-enhanced MR imaging with diffusion-weighted imaging on staging hepatic fibrosis.
Ding Y; Rao S; Yang L; Chen C; Zeng M
Radiol Med; 2016 Nov; 121(11):821-827. PubMed ID: 27449761
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive assessment of hepatic fibrosis using gadoxetate-disodium-enhanced 3T MRI.
Jang YJ; Cho SH; Bae JH; Kim GC; Ryeom H; Kim HJ; Shin KM; Lee HJ
Ann Hepatol; 2013; 12(6):926-34. PubMed ID: 24114823
[TBL] [Abstract][Full Text] [Related]
6. Liver fibrosis staging using T1 mapping on gadoxetic acid-enhanced MRI compared with DW imaging.
Ding Y; Rao SX; Zhu T; Chen CZ; Li RC; Zeng MS
Clin Radiol; 2015 Oct; 70(10):1096-103. PubMed ID: 26164421
[TBL] [Abstract][Full Text] [Related]
7. Staging liver fibrosis by using liver-enhancement ratio of gadoxetic acid-enhanced MR imaging: comparison with aspartate aminotransferase-to-platelet ratio index.
Motosugi U; Ichikawa T; Oguri M; Sano K; Sou H; Muhi A; Matsuda M; Fujii H; Enomoto N; Araki T
Magn Reson Imaging; 2011 Oct; 29(8):1047-52. PubMed ID: 21775085
[TBL] [Abstract][Full Text] [Related]
8. Quantitative assessment of hepatic fibrosis in chronic hepatitis B and C: T1 mapping on Gd-EOB-DTPA-enhanced liver magnetic resonance imaging.
Pan S; Wang XQ; Guo QY
World J Gastroenterol; 2018 May; 24(18):2024-2035. PubMed ID: 29760545
[TBL] [Abstract][Full Text] [Related]
9. Value of Texture Analysis on Gadoxetic Acid-enhanced MR for Detecting Liver Fibrosis in a Rat Model.
Xu J; Wang X; Jin ZY; You Y; Wang Q; Wang ST; Xue HD
Chin Med Sci J; 2019 Mar; 34(1):24-32. PubMed ID: 30961777
[TBL] [Abstract][Full Text] [Related]
10. Liver fibrosis: histopathologic and biochemical influences on diagnostic efficacy of hepatobiliary contrast-enhanced MR imaging in staging.
Feier D; Balassy C; Bastati N; Stift J; Badea R; Ba-Ssalamah A
Radiology; 2013 Nov; 269(2):460-8. PubMed ID: 23878281
[TBL] [Abstract][Full Text] [Related]
11. Liver Fibrosis: Deep Convolutional Neural Network for Staging by Using Gadoxetic Acid-enhanced Hepatobiliary Phase MR Images.
Yasaka K; Akai H; Kunimatsu A; Abe O; Kiryu S
Radiology; 2018 Apr; 287(1):146-155. PubMed ID: 29239710
[TBL] [Abstract][Full Text] [Related]
12. Diffusion-weighted MRI-based Virtual Elastography for the Assessment of Liver Fibrosis.
Kromrey ML; Le Bihan D; Ichikawa S; Motosugi U
Radiology; 2020 Apr; 295(1):127-135. PubMed ID: 32043948
[TBL] [Abstract][Full Text] [Related]
13. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
Lee MH; Kim SH; Park MJ; Park CK; Rhim H
AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
[TBL] [Abstract][Full Text] [Related]
14. Diffusion kurtosis imaging with the breath-hold technique for staging hepatic fibrosis: A preliminary study.
Yoshimaru D; Miyati T; Suzuki Y; Hamada Y; Mogi N; Funaki A; Tabata A; Masunaga A; Shimada M; Tobari M; Nishino T
Magn Reson Imaging; 2018 Apr; 47():33-38. PubMed ID: 29158186
[TBL] [Abstract][Full Text] [Related]
15. Staging liver fibrosis on multiparametric MRI in a rabbit model with elastography, susceptibility-weighted imaging and T1ρ imaging: a preliminary study.
Zou LQ; Zhao F; Zhang H; Zhang K; Xing W
Acta Radiol; 2021 Feb; 62(2):155-163. PubMed ID: 32326722
[TBL] [Abstract][Full Text] [Related]
16. Assessment of liver fibrosis with gadoxetic acid-enhanced MRI: comparisons with transient elastography, ElastPQ, and serologic fibrosis markers.
Jang HJ; Min JH; Lee JE; Shin KS; Kim KH; Choi SY
Abdom Radiol (NY); 2019 Aug; 44(8):2769-2780. PubMed ID: 31041497
[TBL] [Abstract][Full Text] [Related]
17. Value of diffusion-weighted MRI for assessing liver fibrosis and cirrhosis.
Sandrasegaran K; Akisik FM; Lin C; Tahir B; Rajan J; Saxena R; Aisen AM
AJR Am J Roentgenol; 2009 Dec; 193(6):1556-60. PubMed ID: 19933647
[TBL] [Abstract][Full Text] [Related]
18. Gd-EOB-DTPA-enhanced MR imaging: prediction of hepatic fibrosis stages using liver contrast enhancement index and liver-to-spleen volumetric ratio.
Goshima S; Kanematsu M; Watanabe H; Kondo H; Kawada H; Moriyama N; Bae KT
J Magn Reson Imaging; 2012 Nov; 36(5):1148-53. PubMed ID: 22848019
[TBL] [Abstract][Full Text] [Related]
19. Staging hepatic fibrosis: comparison of gadoxetate disodium-enhanced and diffusion-weighted MR imaging--preliminary observations.
Watanabe H; Kanematsu M; Goshima S; Kondo H; Onozuka M; Moriyama N; Bae KT
Radiology; 2011 Apr; 259(1):142-50. PubMed ID: 21248234
[TBL] [Abstract][Full Text] [Related]
20. Assessment of liver fibrosis in rats by MRI with apparent diffusion coefficient and T1 relaxation time in the rotating frame.
Hu G; Zhang X; Liang W; Zhong X; Chan Q; Lin X; Lin T; Li Y; Quan X
J Magn Reson Imaging; 2016 May; 43(5):1082-9. PubMed ID: 26497954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
